USFDA completes pre-approval inspection at Bajaj Healthcare’s API facility in Gujarat

18 Nov 2022 Evaluate

United State Food and Drug Administration (USFDA) has successfully completed pre-approval inspection at Bajaj Healthcare’s API facility located at Vadodara, Gujarat with ZERO 483 observation. USFDA has conducted pre- approval inspection of its API facility from November 14, 2022 to November 17, 2022.

Bajaj Healthcare mainly focuses on development, manufacturing and supply of Amino Acids, Nutritional Supplements and Active Pharmaceutical Ingredients (API) for Pharmaceutical, Nutraceuticals and Food industries.

Bajaj Healthcare Share Price

559.00 89.90 (19.16%)
18-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1800.30
Dr. Reddys Lab 1275.05
Cipla 1472.05
Lupin 2098.70
Zydus Lifesciences 979.10
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.